Description
Book SynopsisPolycystic Ovarian Syndrome and Increased Risk of Female Cancers.- Tumor-infiltrating lymphocytes (TILs) and Gynecological Cancers.- CD133 as Biomarker and Therapeutic Target in Gynecological Cancers.- Cervical Cancer Natural History, Diagnosis, and Management: From Molecular Events to Clinical Management.- Potential Roles of Infiltrated Immune Cells in the Tumour Microenvironment of Endometrial Cancer.- Metabolomic Profiling as a Promising Tool for the Noninvasive Detection of Endometrial Cancer.- Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.- The Gene Expression and Mutations in Ovarian Cancer: Current Findings and Applications.- The Role of Secondary Cytoreductive Surgery in Ovarian Cancer.- Piwi interacting RNAs (piRNAs) in Ovarian Cancer.- The Role of PARP Inhibitors in the Treatment of Advanced Epithelial Ovarian Carcinoma.- Bariatric Surgery and Female Cancers.- Quantum MicroRNA Surveillance against Cancer: Parallel Dimensional Analysis of Integrated Networks by Quantum MicroRNA Language in Female Genital Neoplasms.- Precise Identification of Different Cervical Intraepithelial Neoplasia (CIN) Stages, Using Biomedical Engineering Combined with Data Mining and Machine Learning.
